Patents by Inventor Mark Douglas Davies

Mark Douglas Davies has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • vWFA and/or ANTIG domain containing proteins
    Patent number: 8222371
    Abstract: Proteins (INSP141, INSP142, INSP143, and INSP144) identified as anthrax receptor-like proteins containing von Willebrand factor A (vWFA) and Anthrax receptor extracellular (ANT_IG) domains and the use of these proteins and nucleic acid sequences from the encoding genes in the diagnosis, prevention and treatment of disease are described.
    Type: Grant
    Filed: October 28, 2005
    Date of Patent: July 17, 2012
    Assignee: Ares Trading S.A.
    Inventors: Mark Douglas Davies, David Michalovich, Melanie Yorke, Christine Power
  • Cystine-Knot Fold Cytokine
    Publication number: 20100048467
    Abstract: This invention relates to a novel protein (INSP002), herein identified as a secreted protein that is a member of the Dan family of the cystine-knot fold cytokine superfamily and to the use of this protein and nucleic acid sequences from the encoding genes in the diagnosis, prevention and treatment of disease.
    Type: Application
    Filed: January 12, 2006
    Publication date: February 25, 2010
    Applicant: ARES TRADING S.A.
    Inventors: Mark Douglas Davies, Christopher Benjamin Phelps, Richard Joseph Fagan, Christine Power, Melanie Yorke, Mark Ibberson, Yan Lavrovsky
  • Cystine-knot fold protein
    Patent number: 7619065
    Abstract: This invention relates to a novel protein (INSP002), herein identified as a secreted protein that is a member of the Dan family of the cystine-knot fold cytokine superfamily and to the use of this protein and nucleic acid sequences from the encoding genes in the diagnosis, prevention and treatment of disease.
    Type: Grant
    Filed: June 21, 2004
    Date of Patent: November 17, 2009
    Assignee: Ares Trading S.A.
    Inventors: Mark Douglas Davies, Christopher Benjamin Phelps, Richard Joseph Fagan, Christine Power, Melanie Yorke, Mark Ibberson
  • vWFA and/or ANT_IG Domain Containing Proteins
    Publication number: 20090104197
    Abstract: This invention relates to novel proteins (herein termed INSP141, INSP142, INSP143, and INSP144), herein identified as anthrax receptor-like proteins containing von Willebrand factor A (vWFA) and Anthrax receptor extracellular (ANT_IG) domains and to the use of these proteins and nucleic acid sequences from the encoding genes in the diagnosis, prevention and treatment of disease.
    Type: Application
    Filed: October 28, 2005
    Publication date: April 23, 2009
    Applicant: Ares Trading S.A.
    Inventors: Mark Douglas Davies, David Michalovich, Melanie Yorke, Christine Power
  • IL-8 Like Protein
    Publication number: 20080199435
    Abstract: This present invention relates to a novel protein, termed INSP085, herein identified as an IL-8 like protein and to the use of this protein and nucleic acid sequence from the encoding genes in the diagnosis, prevention and treatment of disease.
    Type: Application
    Filed: March 11, 2008
    Publication date: August 21, 2008
    Inventors: Richard Fagan, Christopher Benjamin Phelps, Mark Douglas Davies, Christine Power
  • IL-8 like protein
    Patent number: 7341851
    Abstract: This present invention relates to a novel protein, termed INSP085, herein identified as an IL-8 like protein and to the use of this protein and nucleic acid sequence from the encoding genes in the diagnosis, prevention and treatment of disease.
    Type: Grant
    Filed: February 18, 2005
    Date of Patent: March 11, 2008
    Assignee: Ares Trading, S.A.
    Inventors: Richard Fagan, Christopher Benjamin Phelps, Mark Douglas Davies, Christine Power